Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F66Q3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,053
Award facts
- Contract value 100% obligated
- $10,053.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 26, 2026, by the Defense Logistics Agency for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $10,053.17 and a completion date of January 27, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The contract is executed under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 31, 2031), which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp operates from its corporate headquarters in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, ranging from specialty medications to vaccines and medical devices. This delivery order aligns with DLA's ongoing pharmaceutical supply chain operations, supporting the Defense Health Agency and other government healthcare systems with essential medications required by military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F66Q3?
SPE2DR26F66Q3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F66Q3 worth?
The government has obligated $10,053 on SPE2DR26F66Q3.
Is contract SPE2DR26F66Q3 an order under another contract?
Yes. SPE2DR26F66Q3 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66Q3 competed?
The extent of competition for SPE2DR26F66Q3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award